Back to Journals Integrated Pharmacy Research and Practice Volume 14 Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity Authors Alzahrani AM, Alshobragi GA, Alshehri AM, Alzahrani MS, Alshehri HA, Alzhrani RM, Basudan S, Alkatheeri AA, Almutairi SA, Alzahrani YA Received 12 November 2024 Accepted for publication 13 March 2025 Published 6 April 2025 Volume 2025:14 Pages 5972 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Walid Al-Qerem Abdullah M Alzahrani, 1 3 Ghada A Alshobragi, 1 Abdullah M Alshehri, 1 Majed S Alzahrani, 1 Hasan A Alshehri, 1 Rami M Alzhrani, 4 Samah Basudan, 5 Ayed A Alkatheeri, 6 Salman A Almutairi, 7 Yahya A Alzahrani 2, 6 1 Pharmaceutical Care Department, Ministry of National GuardHealth Affairs, Jeddah, 22384, Saudi Arabia
Aktywacja MC1R przez -MSH (i jego analogi) podnosi cAMP i przesuwa melanogenez w stron eumelaniny zamiast feomelaniny
The progressive form, MASH, exhibits hepatocyte damage, inflammatory cell infiltration, and variable degrees of tissue fibrosis, with advanced fibrosis representing the predominant prognostic determinant for hepatic morbidity and mortality, as well as an additional risk factor for extrahepatic complications
The regulatory effect of phytochemicals on chronic diseases by targeting Nrf2-ARE signaling pathway
Conventional chemotherapeutic drugs
However, Mounjaros dual hormone action may provide more comprehensive metabolic benefits
